Paul Shaughnessy

3.9k citations
85 papers · 1.8k indexed · 1 hit paper · h-index 20
Topics
Hematopoietic Stem Cell Transplantation (38 papers)CAR-T cell therapy research (27 papers)Multiple Myeloma Research and Treatments (13 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Paul Shaughnessy

72 papers receiving 1.7k citations

Hit Papers

First- and Second-Line Systemic Treatment of Acute Graft-...20122026201620212012100200300400

Peers

Paul Shaughnessy
Comparison fields: 5 of 85
  • Hematology 1.3k
  • Oncology 508
  • Immunology 494
  • Molecular Biology 274
  • Genetics 269
Replace Taiga Nishihori with:
Taiga Nishihori United States
JM Rappeport United States
Leonard T. Heffner United States
WJ Miller United States
Hirohito Yamazaki Japan
Kavitha M. Lakshmi India
Antonella Geromin Italy
Danielle M. Townsley United States
Attaphol Pawarode United States
JW Fay United States
Paul Shaughnessy relative to Taiga Nishihori United States Taiga Nishihori's profile →
Citations per field
00.5×
Taiga Nishihori · 1×
Citations per year

Countries citing papers authored by Paul Shaughnessy

Since Specialization
Citations

This map shows the geographic impact of Paul Shaughnessy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Shaughnessy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Shaughnessy more than expected).

Fields of papers citing papers by Paul Shaughnessy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Shaughnessy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Shaughnessy. The network helps show where Paul Shaughnessy may publish in the future.

Co-authorship network of co-authors of Paul Shaughnessy

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Shaughnessy. A scholar is included among the top collaborators of Paul Shaughnessy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Shaughnessy. Paul Shaughnessy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 1
5 0
6 1
7 5
8 4
9 1
10 1
11 11
12 110
13 51
14 1
15 1
16 21
17 25
18 4
19 31
20
A phase I-II clinical trial with a combination of gemcitabine (GEMZAR) and paclitaxel (TAXOL) for the treatment of refractory multiple myeloma (MM) patients
3

About Paul Shaughnessy

Paul Shaughnessy is a scholar working on Hematology, Transplantation and Oncology, having authored 85 papers that have together received 1.8k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (38 papers), CAR-T cell therapy research (27 papers) and Multiple Myeloma Research and Treatments (13 papers). The work is most often cited by research in Hematology (1.3k citations), Transplantation (123 citations) and Genetics (269 citations). Paul Shaughnessy has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Paul A. Carpenter, John R. Wingard, Yair Gazitt, Bipin N. Savani, Jeffrey Schriber, Corey Cutler, Paul J. Martin, Donna A. Wall, Peter Curtin and Mark R. Litzow. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026